Chembio Diagnostics Inc. buy stratec
Start price
01.04.20
/
50%
€6.55
Target price
04.11.21
€15.00
Performance (%)
-71.76%
End price
05.11.21
€1.85
Summary
This prediction ended on 05.11.21 with a price of €1.85. Massive losses of -71.76% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chembio Diagnostics Inc. | - | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by stratec for this prediction
In the thread Chembio Diagn.new diskutieren
Kantor Fitzgerald erneuert sein Buy-Rating mit $7-Preisziel. Chembio Diagnostik stellt Point-of-Care (POC)-Diagnosetests her, die zur Erkennung oder Diagnose von Krankheiten verwendet werden.
Kursziel geändert auf 15,0
In the thread Trading Chembio Diagn.new
Die von stratec gewählte maximale Laufzeit wurde überschritten